Oxford Science Enterprises a university-partnered venture firm, investing in early-stage life science, AI &a; software, and deep tech.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 46 Woodstock Road
City: Oxford
State: england
Zip: OX2 6HT
Country: GB
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2016 | Vaccitech | Seed Round | 12.4M |
5/2017 | Ultromics | Seed Round | 2.6M |
5/2019 | Albus Health | Convertible Note | 580.9k |
2/2022 | First Light Fusion | Series C | 45M |
12/2021 | Alethiomics | Seed Round | 8M |
12/2016 | EnzBond | Seed Round | 445.3k |
6/2022 | ORCA Computing | Series A | 15M |
8/2017 | OxMet Technologies | Seed Round | 2.6M |
5/2016 | Evox Therapeutics | Series A | 14.4M |
6/2020 | Oxford Ionics | Seed Round | 3.4M |
1/2016 | Oxford Flow | Seed Round | - |
10/2016 | DJS Antibodies | Seed Round | - |
3/2016 | Diffblue | Seed Round | - |
7/2022 | Oxford Quantum Circuits | Series A | 45.4M |
1/2016 | Mixergy Ltd. | Seed Round | - |
3/2017 | Oxford Semantic Technologies | Seed Round | - |
6/2017 | Scenic Biotech | Series A | 7.3M |
9/2018 | Oxford VR | Venture Round | 4.2M |
8/2018 | Edplus | Pre Seed Round | 643.5k |
5/2021 | Omega Crop | Seed Round | 1.7M |
12/2018 | Genomics | Series B | 9.1M |
1/2018 | Pepgen | Seed Round | - |
3/2021 | Genomics | Venture Round | 30M |
1/2020 | OxMet Technologies | Series B | 14.1M |
11/2015 | Bodle Technologies | Seed Round | - |
11/2017 | Quantum Motion Technologies | Seed Round | - |
10/2016 | Argonaut Therapeutics | Seed Round | - |
4/2020 | BibliU | Series A | 10M |
7/2019 | Zegami | Series B | 1.6M |
7/2021 | Orbit Discovery | Venture Round | 0 |
6/2015 | OxStem | Seed Round | - |
12/2021 | ONI | Series B | 75M |
12/2016 | Circadian Therapeutics | Venture Round | 2.5M |
6/2018 | Metaboards | Series A | 0 |
7/2020 | PQShield | Seed Round | 6.9M |
6/2018 | BibliU | Seed Round | 3.8M |
4/2018 | Oxford Flow | Venture Round | 8.5M |
7/2016 | Oxford Impedance Diagnostics Ltd. | Seed Round | 2.6M |
1/2021 | Living Optics | Seed Round | 0 |
5/2018 | Orbit Discovery | Series A | 0 |
11/2017 | First Light Fusion | Venture Round | - |
1/2017 | Oxford VR | Seed Round | - |
12/2022 | BehaVR | Series B | 0 |
10/2018 | Animal Dynamics | Series A | 0 |
5/2018 | Ultromics | Series A | 0 |
6/2022 | BibliU | Series B | 0 |
9/2018 | Evox Therapeutics | Series B | 0 |
3/2018 | Xerion Healthcare | Venture Round | 2.8M |
3/2022 | Scenic Biotech | Series A | 0 |
12/2021 | Navenio | Venture Round | 0 |
7/2019 | Zegami | Series B | 1.6M |
1/2017 | Covatic | Seed Round | 896.6k |
7/2021 | Rey | Series A | 10M |
3/2021 | Caristo Diagnostics | Venture Round | - |
4/2023 | Caristo Diagnostics | Series A | 0 |
3/2023 | Mixergy | Venture Round | 0 |
3/2023 | Quantrol Ox | Seed Round | 0 |
2/2023 | Archangel Lightworks | Seed Round | 0 |
2/2017 | BibliU | Seed Round | 1.4M |
7/2018 | ONI | Series A | 24M |
2/2020 | Oxford VR | Series A | 0 |
10/2018 | Caristo Diagnostics | Seed Round | 2.6M |
8/2019 | MoA Technology | Series A | 7.6M |
11/2022 | Util | Seed Round | 0 |
1/2023 | Grey Wolf Therapeutics | Series B | 0 |
6/2020 | Base Genomics | Seed Round | 11.3M |
5/2018 | Opsydia | Seed Round | 2.5M |
5/2016 | ONI | Seed Round | 1.7M |
6/2023 | Beacon Therapeutics | Series A | 0 |
2/2018 | Odqa Renewable Energy Technologies | Seed Round | 570.6k |
12/2019 | Mixergy Ltd. | Series A | 0 |
9/2022 | Opsydia | Venture Round | 0 |
10/2019 | MiroBio | Series A | 33.2M |
7/2020 | ORCA Computing | Pre Seed Round | - |
4/2020 | Perspectum | Series B | 35.9M |
6/2020 | Oxford Flow | Venture Round | 0 |
8/2017 | Inkpath | Series A | - |
5/2018 | PQShield | Seed Round | - |
2/2018 | Latent Logic | Seed Round | 2M |
6/2022 | MiroBio | Series B | 0 |
2/2021 | Evox Therapeutics | Series C | 96.7M |
3/2021 | Vaccitech | Series B | 168M |
5/2018 | Util | Seed Round | 1.1M |
10/2018 | Covatic | Seed Round | 1.1M |
6/2019 | Oxford Semantic Technologies | Series A | 3.8M |
1/2023 | Amber Therapeutics | Seed Round | - |
12/2020 | DJS Antibodies | Venture Round | 0 |
3/2017 | Bodle Technologies | Seed Round | - |
6/2015 | Proxisense | Seed Round | - |
9/2016 | Iota Sciences | Seed Round | - |
6/2017 | Diffblue | Series A | 21.8M |
11/2017 | Albus Health | Convertible Note | 66.6k |
1/2022 | PQShield | Series A | 0 |
8/2021 | Pepgen | Venture Round | 0 |
1/2021 | Theolytics | Series A | 6.8M |
12/2020 | Pepgen | Series A | 45M |
12/2015 | Navenio | Seed Round | 2.6M |
5/2022 | Salience Labs | Seed Round | 11.5M |
7/2022 | Brill Power | Series A | 0 |
3/2017 | SpyBiotech | Seed Round | 5M |
11/2018 | OMass Technologies | Series A | 17.9M |
6/2016 | OMass Technologies | Seed Round | 1.4M |
2/2020 | OMass Technologies | Series A | 35.8M |
1/2023 | Oxford Ionics | Series A | 0 |
2/2016 | Mind Foundry | Seed Round | 1.7M |
1/2018 | Vaccitech | Series A | 0 |
1/2018 | Bodle Technologies | Series A | 8.5M |
12/2020 | T-Cypher Bio | Seed Round | - |
9/2011 | Oxtex | Seed Round | 800k |
3/2018 | 6D.ai | Seed Round | - |
11/2018 | OxMet Technologies | Series A | 7.8M |
6/2017 | Zegami | Series A | 3M |
10/2022 | Nucleome Therapeutics | Series A | 42.3M |
9/2018 | Oxford VR | Seed Round | 4.2M |
4/2020 | Living Optics | Seed Round | 4.1M |
3/2017 | Pro-Mapp | Seed Round | - |
11/2022 | Osler Diagnostics | Series C | 0 |
9/2017 | Oxford Quantum Circuits | Series A | - |
4/2017 | ONI | Seed Round | 3.7M |
8/2018 | Genomics | Series B | 32.5M |
5/2022 | MoA Technology | Series B | 0 |
9/2019 | YASA | Series C | 22.2M |
9/2017 | Mind Foundry | Seed Round | 3.4M |
8/2021 | Ultromics | Series B | 0 |
4/2021 | Oxford Endovascular | Series A | 0 |
2/2021 | SpyBiotech | Series A | 32.5M |
11/2020 | Refeyn | Series A | 30M |
8/2018 | BioBeats | Seed Round | 3M |
12/2017 | Navenio | Funding Round | 7.7M |
5/2020 | Navenio | Series A | 0 |
2/2023 | Quantum Motion | Series B | 0 |
5/2020 | Quantum Motion Technologies | Series A | 9.8M |
4/2022 | OMass Technologies | Series B | 0 |
12/2017 | Theolytics | Seed Round | 3.4M |
4/2023 | Caristo Diagnostics | Series A | 0 |
3/2023 | Mixergy | Venture Round | 0 |
3/2023 | Quantrol Ox | Seed Round | 0 |
2/2023 | Quantum Motion | Series B | 0 |
2/2023 | Archangel Lightworks | Seed Round | 0 |
1/2023 | Grey Wolf Therapeutics | Series B | 0 |
1/2023 | Amber Therapeutics | Seed Round | - |
1/2023 | Oxford Ionics | Series A | 0 |
12/2022 | BehaVR | Series B | 0 |
11/2022 | Osler Diagnostics | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|